PedAM
Pediatric Disease Annotations & Medicines
| Disease | irritable bowel syndrome |
| Symptom | C0030193|pain |
| Sentences | 34 |
| PubMedID- 23320954 | The aim of this study was to examine whether irritable bowel syndrome (ibs) is associated with increased somatic pain sensitivity in a large population-based sample and to test whether this association was independent of sex, age, comorbid chronic pain, and psychological distress. |
| PubMedID- 25077526 | In summary, the combination of palonosetron with a nk1 receptor antagonist showed synergistic analgesic activity in rodent models of somatic and visceral hypersensitivity, and may prove to be a useful therapeutic approach to treat pain associated with irritable bowel syndrome. |
| PubMedID- 23412008 | irritable bowel syndrome in women with chronic pelvic pain in a northeast brazilian city. |
| PubMedID- 24667275 | The crohn’s disease activity index, which is widely used in cd patients, has been proven quite inaccurate in this context (for instance, the score might be raised in the absence of inflammation because of diarrhea and pain due to irritable bowel syndrome or bacterial overgrowth) . |
| PubMedID- 24298588 | Trimebutine, an antispasmodic drug, is used to relieve pain associated with irritable bowel syndrome, despite a lack of proven efficacy. |
| PubMedID- 23257146 | Objective: acupuncture is widely used in clinics to suppress chronic visceral pain in patients with irritable bowel syndrome (ibs); however, the exact neurobiological mechanisms for its therapeutic effects need further exploration. |
| PubMedID- 25581334 | Symptom-association probability between meal ingestion and abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 21914041 | Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. |
| PubMedID- 21481494 | Recurrent abdominal pain in a patient with irritable bowel syndrome. |
| PubMedID- 24456818 | Functional mri has shown that activation of such regions as the prefrontal area is associated with a low visceral pain threshold in patients with irritable bowel syndrome . |
| PubMedID- 23100018 | 2a 37-year-old female patient presented with chronic abdominal pain and was suspected of having irritable bowel syndrome. |
| PubMedID- 25052366 | The non-clinical programme for ppc-5650 supported a role for this novel agent in the treatment of pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 22493949 | Tripolar spinal cord stimulation for the treatment of abdominal pain associated with irritable bowel syndrome. |
| PubMedID- 26311432 | A clinical study found that riluzole produced pain relief in patients with irritable bowel syndrome . |
| PubMedID- 26290286 | Background: consensus on standard methods to assess chronic abdominal pain in patients with irritable bowel syndrome (ibs) is currently lacking. |
| PubMedID- 24733123 | Chronic visceral pain in patients with irritable bowel syndrome (ibs) has been difficult to treat effectively partially because its pathophysiology is not fully understood. |
| PubMedID- 24095618 | Background: in prior studies, pregabalin reduced rectal or colonic pain in patients with irritable bowel syndrome and healthy adults, suggesting reduction of afferent function. |
| PubMedID- 25488056 | Thus, saccharomyces cerevisiae may be a new promising candidate for improving abdominal pain in subjects with irritable bowel syndrome. |
| PubMedID- 26486119 | We present one such case of early closure in a 32-year-old male with recurrent abdominal pain who was diagnosed with irritable bowel syndrome (ibs). |
| PubMedID- 19800336 | Background & aims: chronic stress exacerbates or causes relapse of symptoms such as abdominal pain and cramping in patients with irritable bowel syndrome. |
| PubMedID- 21513946 | Seven out of 20 subjects (35%) met the rome iii criteria for diagnosis of a pain-associated fgid (3 with irritable bowel syndrome, 2 with functional dyspepsia, and 2 with functional abdominal pain), and 1 patient in the control group (with irritable bowel syndrome) met these criteria (or, 6.8; 95% ci, 0.82-56; p = .043). |
| PubMedID- 25703594 | Methods: we report 2 sisters with an uncommon presentation of lopd characterized by fibromyalgia-like pain associated with irritable bowel syndrome. |
| PubMedID- 23490035 | Mechanical hypersensitivity of colon afferents in part underlies the chronic pain of patients with irritable bowel syndrome. |
| PubMedID- 21448146 | Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting rome iii criteria. |
| PubMedID- 22500715 | Objective: acupuncture has been clinically proved to be effective in treating abdominal pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 20371236 | Trimebutine maleate, which modulates the calcium and potassium channels, relieves abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 23583433 | Background & aims: simultaneous agonism of the mu-opioid receptor and antagonism of the delta-opioid receptor can reduce abdominal pain and diarrhea in patients with irritable bowel syndrome with diarrhea (ibs-d) without constipating side effects. |
| PubMedID- 22550579 | The effect of topical local anesthetics on thermal pain sensitivity in patients with irritable bowel syndrome. |
| PubMedID- 22738315 | Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 22937879 | Background: mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 26270949 | A review and several meta-analyses of randomised, double blind, placebo-controlled trials in adults have demonstrated that pmo is effective in reducing abdominal pain in patients with irritable bowel syndrome (ibs).13–7 however, in children with ibs, there is a dearth of information restricted to a single small (n=42), double blind, placebo-controlled trial.7 nonetheless, the use of pmo as an adjunctive measure to treat children with ibs continues to evolve in clinical practice despite the lack of any information pertaining to the impact of age and/or disease state on its pharmacodynamics (pds) or pharmacokinetics (pks). |
| PubMedID- 25206515 | Chronic visceral hypersensitivity has been shown to be the main pathophysiological mechanism underlying abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 24419306 | Objective: this randomized trial evaluated the therapeutic effect of emotional awareness training on the severity and frequency of pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 22960405 | Background: rose-010, a glucagon-like peptide-1 (glp-1) analog, reduces gastrointestinal motility and relieves acute pain in patients with irritable bowel syndrome (ibs). |
Page: 1